Abstract
Fibromyalgia syndrome (FMS) is a chronic pain disorder characterised by widespread musculoskeletal pain, fatigue, and cognitive dysfunction, with no definitive biomarkers or mechanism-based treatments. Emerging evidence suggests that immune dysregulation may contribute to the FMS...
Dated from April 2019, but I don't think this has been posted before.
I had thought most B-cell related work would've ended with the Rituximab trial failure, but apparently not:
https://discovery.ucl.ac.uk/id/eprint/10080812/20/Mensah_10080812_thesis_redacted.pdf
Just starting to work my way...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.